231 related articles for article (PubMed ID: 8102318)
1. Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans.
Mizunashi K; Furukawa Y; Katano K; Abe K
Calcif Tissue Int; 1993 Jul; 53(1):21-5. PubMed ID: 8102318
[TBL] [Abstract][Full Text] [Related]
2. Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children.
Kocsis I; Arató A; Bodánszky H; Szönyi L; Szabó A; Tulassay T; Vásárhelyi B
Calcif Tissue Int; 2002 Aug; 71(2):129-32. PubMed ID: 12200646
[TBL] [Abstract][Full Text] [Related]
3. Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo.
Sheraly AR; Lickorish D; Sarraf F; Davies JE
Curr Drug Deliv; 2009 Apr; 6(2):192-8. PubMed ID: 19450226
[TBL] [Abstract][Full Text] [Related]
4. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.
Lems WF; Gerrits MI; Jacobs JW; van Vugt RM; van Rijn HJ; Bijlsma JW
Ann Rheum Dis; 1996 May; 55(5):288-93. PubMed ID: 8660101
[TBL] [Abstract][Full Text] [Related]
5. Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females.
Weaver CM; Peacock M; Martin BR; McCabe GP; Zhao J; Smith DL; Wastney ME
J Bone Miner Res; 1997 Oct; 12(10):1714-20. PubMed ID: 9333133
[TBL] [Abstract][Full Text] [Related]
6. Impact of omeprazole on bone remodeling in normal and ovariectomized Wistar rats.
Hasanin AH
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1948-56. PubMed ID: 25010627
[TBL] [Abstract][Full Text] [Related]
7. Increased bone resorption and decreased bone formation in Chinese patients with hip fracture.
Cheung CK; Panesar NS; Lau E; Woo J; Swaminathan R
Calcif Tissue Int; 1995 May; 56(5):347-9. PubMed ID: 7621338
[TBL] [Abstract][Full Text] [Related]
8. [Movement of gastric acid secretion and influence of proton pump inhibitors on histamine H2 receptor antagonist resistant ulcer].
Asaki S; Kimpara T; Ohara S; Hongo M
Nihon Rinsho; 1992 Jan; 50(1):111-5. PubMed ID: 1347323
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effect of antiulcer agents on granulocytes--a role for granulocytes in gastric ulcer formation.
Kawamura T; Miyaji C; Toyabe S; Fukuda M; Watanabe H; Abo T
Dig Dis Sci; 2000 Sep; 45(9):1786-91. PubMed ID: 11052321
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
12. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
Asaka M; Kato M; Sato Y; Miyazaki T
Nihon Rinsho; 1992 Jan; 50(1):104-10. PubMed ID: 1347322
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
Tomita T; Kim Y; Yamasaki T; Okugawa T; Kondo T; Toyoshima F; Sakurai J; Tanaka J; Morita T; Oshima T; Fukui H; Hori K; Watari J; Matsumoto T; Miwa H
J Gastroenterol Hepatol; 2012 Sep; 27(9):1441-6. PubMed ID: 22497427
[TBL] [Abstract][Full Text] [Related]
14. [Endoscopic ultrasonographic study of gastric ulcer treated with proton pump inhibitor].
Yoshino J; Nakazawa S; Nakamura T; Yamao K; Inui K; Yamachika H; Watanabe K; Wakabayashi T
Nihon Rinsho; 1992 Jan; 50(1):81-5. PubMed ID: 1347334
[TBL] [Abstract][Full Text] [Related]
15. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
Shamburek RD; Schubert ML
Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
[TBL] [Abstract][Full Text] [Related]
16. [Endoscopic stage classification of peptic ulcer and characterization of the healing process by proton pump inhibitors].
Karasawa H; Miwa T
Nihon Rinsho; 1992 Jan; 50(1):74-80. PubMed ID: 1347333
[TBL] [Abstract][Full Text] [Related]
17. Direct comparison between the ulcer-healing effects of two H(+)-K(+)-ATPase inhibitors, one M1-selective antimuscarinic and one H2 receptor antagonist in the rat.
Kromer W; Gönne S; Riedel R; Postius S
Pharmacology; 1990; 41(6):333-7. PubMed ID: 1982899
[TBL] [Abstract][Full Text] [Related]
18. [Endoscopic studies on refractory gastric ulcers, especially, linear ulcers, treated with proton pump inhibitor].
Takase S; Takada A
Nihon Rinsho; 1992 Jan; 50(1):116-21. PubMed ID: 1347324
[TBL] [Abstract][Full Text] [Related]
19. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
20. Pantoprazole versus omeprazole in the treatment of acute gastric ulcers.
Witzel L; Gütz H; Hüttemann W; Schepp W
Aliment Pharmacol Ther; 1995 Feb; 9(1):19-24. PubMed ID: 7766739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
